A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells**-Reference-Cited by-同舟云学术

A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells**

Published:2022-01-18 Issue: Volume: Page:
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angewandte Chemie Intl Edit

Author:

Cao Wenyue¹²,Geng Zhi Zachary²,Wang Na¹,Pan Quan²,Guo Shaodong²,Xu Shiqing²^ORCID,Zhou Jianfeng¹,Liu Wenshe Ray²³⁴⁵^ORCID

Affiliation:

1. Department of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

2. The Texas A&M Drug Discovery Laboratory Department of Chemistry Texas A&M University College Station TX 77843-3255 USA

3. Institute of Biosciences and Technology and Department of Translational Medical Sciences College of Medicine Texas A&M University Houston TX 77030 USA

4. Department of Biochemistry and Biophysics Texas A&M University Houston TX 77843 USA

5. Department of Molecular and Cellular Medicine College of Medicine Texas A&M University Houston TX 77843 USA

Funder

Welch Foundation

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202109550

Reference36 articles.

2. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

3. Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

4. A guide to manufacturing CAR T cell therapies

5. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies;Biomarker Research;2024-07-29

2. Engineering Anti‐CRISPR Proteins to Create CRISPR‐Cas Protein Switches for Activatable Genome Editing and Viral Protease Detection;Angewandte Chemie International Edition;2024-03-14

3. Engineering Anti‐CRISPR Proteins to Create CRISPR‐Cas Protein Switches for Activatable Genome Editing and Viral Protease Detection;Angewandte Chemie;2024-03-14

4. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy;Molecular Oncology;2024-03-08

5. Chemical immunology: Recent advances in tool development and applications;Cell Chemical Biology;2024-03